Mardia Samyoung Capillary Tubes Submits Unaudited Q3FY26 Financial Results
Mardia Samyoung Capillary Tubes Company Limited has submitted its unaudited standalone financial results for Q3FY26 ended December 31, 2025, following board approval on January 24, 2026. The company completed its regulatory obligations under SEBI (LODR) Regulations 2015 by submitting newspaper publication copies to BSE Limited on January 28, 2026. The detailed financial results are accessible on stock exchange and company websites, with Managing Director Dhaval Dharmendrabhai Joshi overseeing the compliance process.
*this image is generated using AI for illustrative purposes only.
Mardia Samyoung Capillary Tubes Company Limited has completed the submission of its unaudited standalone financial results for the third quarter ended December 31, 2025, marking another regulatory milestone for the Mumbai-based company. The submission follows the company's board meeting held on January 24, 2026, where directors formally approved the quarterly financial performance.
Regulatory Compliance and Documentation
The company has fulfilled its obligations under Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, by submitting newspaper publication copies to BSE Limited. The submission was made on January 28, 2026, with proper documentation including digital signatures from Managing Director Dhaval Dharmendrabhai Joshi.
| Parameter: | Details |
|---|---|
| Quarter Period: | Ended December 31, 2025 |
| Board Meeting Date: | January 24, 2026 |
| Submission Date: | January 28, 2026 |
| Regulation: | SEBI (LODR) Regulations 2015 |
| BSE Scrip Code: | 513544 |
Company Information and Structure
Mardia Samyoung Capillary Tubes Company Limited operates with its registered office located at A-108, 1st Floor, Chikuwadi, Western Express Highway, Andheri East, Mumbai - 400099. The company maintains its corporate office in Gujarat at Shop-511 Pratik Mall, Near City Pulse Theatre, Kudasan, Gandhi Nagar, Gandhinagar, Gujarat, India, 382421.
The company's CIN L74999MH1992PLC069104 reflects its incorporation in Maharashtra in 1992. Managing Director Dhaval Dharmendrabhai Joshi (DIN: 10778731) oversees the company's operations and regulatory compliance.
Financial Results Accessibility
The detailed quarterly financial results filed under Regulation 33 of the SEBI regulations are accessible through multiple channels. Stakeholders can access the complete financial information on the stock exchange website and the company's official website at https://mardiasamyounglimited.com/ . The company has also provided QR code access for convenient digital viewing of the financial documents.
Board Approval Process
The unaudited standalone financial results received formal approval from the company's board of directors during their meeting on January 24, 2026. This approval process ensures proper governance and oversight of the company's financial reporting, maintaining transparency with shareholders and regulatory authorities.
The submission represents the company's commitment to maintaining regular financial disclosure practices and adhering to stock exchange listing requirements. The availability of results through multiple digital platforms demonstrates the company's focus on stakeholder accessibility and transparency in financial communication.
Source: BSE Filing
15
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
